Comparative Pharmacology
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus MUCINEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMMONIUM CHLORIDE 2 14 versus MUCINEX.
AMMONIUM CHLORIDE 2.14% vs MUCINEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonium chloride is an acidifying agent. It dissociates into ammonium and chloride ions. The ammonium ion is metabolized in the liver to urea and hydrogen ions, leading to metabolic acidosis. This reduces blood pH and increases renal excretion of alkaline urine.
Guaifenesin is an expectorant that increases respiratory tract fluid secretion and reduces mucus viscosity, facilitating its removal.
For metabolic alkalosis: 1.5 to 3 g (approximately 280 to 560 mEq) intravenously over 4 to 6 hours; adjust based on serum chloride and pH.
600 mg orally twice daily (extended-release); for immediate-release: 200 mg orally three times daily or 400 mg orally twice daily.
None Documented
None Documented
4-6 hours; prolonged in renal impairment (up to 12-15 hours).
1-2 hours (terminal elimination half-life); clinical context: rapid clearance requires frequent dosing to maintain mucolytic effect.
Renal: >99% as ammonium ion and chloride; minimal biliary/fecal elimination.
Renal: approximately 50-60% as unchanged drug (guaifenesin) and metabolites; minor biliary/fecal elimination (<10%).
Category C
Category C
Expectorant/Systemic Acidifier
Expectorant